Correlations between NT-proBNP, outcome and haemodynamics in patients with septic shock

References

• Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303–10.
   Google Scholar
• Hotchkiss RS, Karl IE.The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138–50.
   Google Scholar
• Marshall JC, Foster D, Vincent JL, Cook DJ, Cohen J, Dellinger RP, Opal 5, Abraham E, Brett SJ, Smith T, Mehta 5, Derzko A, Romaschin A; MEDIC study. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 2004; 190: 527–34.
   Google Scholar
• Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995; 273: 117–23.
   Google Scholar
• Zambon M, Ceola M, Almeida-de-Castro R, Gullo A, Vincent JL. Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock: we could go faster. J Crit Care 2008; 23:455–60.
   Google Scholar
• Wang F, Wu Y, Tang L, Zhu W, Chen F, Xu T, Bo L, Li J, Deng X. Brain natriuretic peptide for prediction of mortality in patients with sepsis: a systematic review and meta-analysis. Crit Care 2012; 16: R74.
   Google Scholar
• Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321–8.
   Google Scholar
• Vanderheyden M, Bartunek J, Goethals M. Brain and other natriuretic peptides: molecular aspects. Eur J Heart Fail 2004; 6:261–8.
   Google Scholar
• Troisi F, Greco 5, Brunetti ND, Di Biase M. Right heart dysfunction assessed with echography, B-type natriuretic peptide and cardiopulmonary test in patients with chronic heart failure. J Cardiovasc Med 2008; 9:672–6.
   Google Scholar
• Kragelund C, Gronning B, Kober L, Hildebrandt P. Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005; 352:666–75.
   Google Scholar
• De Gennaro L, Brunetti ND, Bungaro R, Montrone D, Cuculo A, Pellegrino PL, Correale M, Di Blase M. Carbohydrate antigen-125: additional accuracy in identifying patients at risk of acute heart failure in acute coronary syndrome. Coron Artery Dis 2009; 20:274–80.
   Google Scholar
• Pieralli F, °Hyatt° I, Vanni 5, Conti A, Camaiti A, Targioni G, Grifoni 5, Berni G. Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism. Am J Cardiol 2006; 97: 1386–90.
   Google Scholar
• Karthikeyan G, Moncur RA, Levine O, Heels-Ansdell D, Chan MT, Alonso-Coello P. Yusuf 5, Sessler D, Villar JC, Berwanger O, McQueen M, Mathew A, Hill 5, Gibson 5, Berry C, Yeh HM, Devereaux PJ. Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J Am Coll Cardiol 2009; 54: 1599–1606.
   Google Scholar
• Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250–6.
   Google Scholar
• Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend 5, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008; 34: 17–60.
   Google Scholar
• Vincent JL, Moreno R, Takala J, Willatts 5, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG.The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707–10.
   Google Scholar
• Le Gall JR, Lemeshow 5, Saulnier F. A New Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957–63.
   Google Scholar
• Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography’s Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echo cardiogr 2005; 18: 1440–63.
   Google Scholar
• Bairn DS, Grossmann W. Cardiac Catheterization, Angiography, and Intervention. 5th ed. Baltimore, Maryland: Williams & Wilkins; 1996.
   Google Scholar
• Court O, Kumar A, Parrillo JE, Kumar A. Clinical review: Myocardial depression in sepsis and septic shock. Crit Care 2002; 6: 500–8.
   Google Scholar
• Maeder M, Fehr T, Rickli H, Ammann P. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 2006; 129: 1349–66.
   Google Scholar
• Varpula M, Pulkki K, Karlsson 5, Ruokonen E, Pettil6 V. FINNSEPSIS Study Group. Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock. Crit Care Med 2007; 35: 1277–83.
   Google Scholar
• Kimmoun A, Ducrocq N, Mory 5, Delfosse R, Muller L, Perez P. Fay R, Levy B. Cardiac contractile reserve parameters are related to prognosis in septic shock. BioMed Research International 2013; (2013), article ID 930673, 7 pages.
   Google Scholar
• Repessé X, Charron C, Vieillard-Baron A. Evaluation of left ventricular systolic function revisited in septic shock. Critical Care 2013; 17: 164 [commentary].
   Google Scholar
• Robotham JL, Takata M, Berman M, Harasawa Y. Ejection fraction revisited. Anesthesiology 1991; 74:172–83.
   Google Scholar
• Giannazzo G, Tola F, Vanni 5, Bondi E, Pepe G, Grifoni S. Prognostic indexes of septic syndrome in the emergency department. Intern Emerg Med 2006; 1: 229–33.
   Google Scholar
• Giamarellos-Bourboulis EJ, Tsangaris I, Kanni T, Mouktaroudi M, Pantelidou I, Adamis G, Atmatzidis 5, Chrisofos M, Evangelopoulou V. Frantzeskaki F, Giannopoulos P. Giannikopoulos G, Gialvalis D, Gourgoulis GM, Kotzampassi K, Katsifa K, Kofinas G, Kontopidou F, Koratzanis G, Koulouras V, Koutsikou A, Koupetori M, Kritselis I, Leonidou L, Mega A, Mylona V. Nikolaou H, Orfanos 5, Panagopoulos P. Paramythiotou E, Papadopoulos A, Papanikolaod X, Pavlaki M, Polychronopoulos V. Skoutelis A, Theodotou A, Vassiliaghou M, Douzinas EE, Gogos C, Armaganidis A, on behalf of the Hellenic Sepsis Study Group. Procalcitonin as an early indicator of outcome in sepsis: a prospective observational study. J Hosp Infect 2011; 77: 58–63.
   Google Scholar
• Choon-ngarm T, Partpisanu P. Serum cardiac troponin-T as a prognostic marker in septic shock. J Med Assoc Thai 2008; 91:1818–21.
   Google Scholar
• Mehta NJ, Khan IA, Gupta V, Jani K, Gowda RM, Smith PR. Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock. Int J Cardiol 2004; 95: 13–7.
   Google Scholar
• Novotny A, Emmanuel K, Matevossian E, Kriner M, Ulm K, Bartels H, Holzmann B, Weighardt H, Siewert JR. Use of procalcitonin for early prediction of lethal outcome of postoperative sepsis. Am J Surg 2007; 194:35–9.
   Google Scholar
• Charles PE, Ladoire 5, Aho 5, Quenot JP, Doise JM, Prin 5, Olsson NO, Blettery B. Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either gram negative or gram positive bacteria. BMC Infect Dis 2008; 26:38.
   Google Scholar
• Dahaba AA, Hagara B, Fall A, Rehak PH, List WF, Metzler H. Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth 2006; 97: 503–8.
   Google Scholar
• Claeys R, Vinken 5, Spapen H, ver Elst K, Decochez K, Huyghens L, Gorus FK. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 2002; 30: 757–62.
   Google Scholar
• Rosjo H, Varpula M, Hagve TA, Karlsson 5, Ruokonen E, Pettil6 V. Omland T; FINNSEPSIS Study Group. Circulating high sensitivity troponin Tin severe sepsis and septic shock: distribution, associated factors, and relation to outcome. Intensive Care Med 2011; 37: 77–85.
   Google Scholar
• Tiruvoipati R, Sultana N, Lewis D. Cardiac troponin I does not independently predict mortality in critically ill patients with severe sepsis. Emerg Med Australas 2012; 24:151–8.
   Google Scholar
• Marshall JC, Foster D, Vincent JL, Cook DJ, Cohen J, Dellinger RP, Opal 5, Abraham E, Brett SJ, Smith T, Mehta 5, Derzko A, Romaschin A; MEDIC study. Source Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 2004; 190:527–34.
   Google Scholar
• Kandil E, BurackJ, Sawas A, BibawyH, Schwartzman A, Zenilman ME, Bluth MH. B-type natriuretic peptide: a biomarker for the diagnosis and risk stratification of patients with septic shock. Arch Surg 2008; 143:242–6.
   Google Scholar
• Rivers EP, Mc Cord J, Otero R, Jacobsen G, Loomba M. Clinical utility of B-type natriuretic peptide in early severe sepsis and septic shock. J Intensive Care Med 2007; 22: 363–73.
   Google Scholar